Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

30.50
-0.3050-0.99%
Volume:161.07K
Turnover:4.94M
Market Cap:1.14B
PE:-30.52
High:30.89
Open:30.55
Low:30.42
Close:30.80
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:0.84
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:75.21
PE(LYR):-217.82

Loading ...

Harrow Says QUELL Trial of Iheezo Posts Topline Data in Q4 2026

Reuters
·
Jul 20

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting

GlobeNewswire
·
Jul 20

Harrow Among 3 Prime Growth Stocks With Significant Insider Ownership

Simply Wall St.
·
Jul 17

Craig-Hallum Sticks to Its Buy Rating for Harrow Health (HROW)

TIPRANKS
·
Jul 13

Harrow (HROW) Could Be 38% Undervalued Following BYOOVIZ Launch

Simply Wall St.
·
Jul 03

Analysts Are Bullish on These Healthcare Stocks: Plus Therapeutics (PSTV), Harrow Health (HROW)

TIPRANKS
·
Jul 01

Harrow Expands Retina Portfolio With US Launch of Byooviz

MT Newswires Live
·
Jul 01

Harrow announces commercial launch of Byooviz in the U.S.

TIPRANKS
·
Jul 01

Samsung Bioepis Relaunches Byooviz® (ranibizumab-nuna) in the United States in Partnership with Harrow

THOMSON REUTERS
·
Jul 01

Harrow Announces Commercial Launch of BYOOVIZ® in the United States

GlobeNewswire
·
Jul 01

Harrow holds annual shareholder meeting, elects four directors

Reuters
·
Jun 22

Harrow (HROW) Stock After VERKAZIA Relaunch A Fresh Look At The Valuation Gap

Simply Wall St.
·
Jun 12

What Harrow (HROW)'s VERKAZIA Re‑Launch in Pediatric VKC Means For Shareholders

Simply Wall St.
·
Jun 11

Harrow Shares Rise on Relaunch of Pediatric Eye Disease Treatment

Dow Jones
·
Jun 10

Harrow Relaunches Verkazia for Vernal Keratoconjunctivitis

MT Newswires Live
·
Jun 10

Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare

THOMSON REUTERS
·
Jun 10

Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), GeneDx Holdings (WGS)

TIPRANKS
·
Jun 10

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 04

Harrow (HROW) Is Up 6.8% After Reaffirming 2026 Revenue Outlook Despite Wider Q1 Losses - What's Changed

Simply Wall St.
·
May 26

Harrow director Adrienne Graves acquires 1,000 common shares for $31,070

Reuters
·
May 19